Synthroid and Sputum retention - a phase IV clinical study of FDA data

Summary:

Sputum retention is reported as a side effect among people who take Synthroid (levothyroxine sodium), especially for people who are female, 60+ old, also take Symbicort, and have Sinus disorder.

The phase IV clinical study analyzes which people have Sputum retention when taking Synthroid. It is created by eHealthMe based on reports of 237,758 people who have side effects when taking Synthroid from the FDA, and is updated regularly.

What is Synthroid?

Synthroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 249,205 Synthroid users. Check the latest studies of Synthroid.

What is Sputum retention?

Sputum retention is found to be associated with 149 drugs and 317 conditions by eHealthMe. Check the latest studies of Sputum retention.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

237,758 people reported to have side effects when taking Synthroid.
Among them, 16 people (0.01%) have Sputum retention.

Among these 16 people:

What is the gender of people who have Sputum retention when taking Synthroid? *

female: 100 %
male: 0.0 %

What is the age of people who have Sputum retention when taking Synthroid? *

What are other drugs people take besides Synthroid? *

What are other side effects people have besides Sputum retention? *

Cough: 12 people, 75.00%
Productive Cough: 12 people, 75.00%
Fatigue (feeling of tiredness): 7 people, 43.75%
Urinary Tract Infection: 6 people, 37.50%
Dyspnea (difficult or laboured breathing): 6 people, 37.50%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 6 people, 37.50%
Diarrhea: 6 people, 37.50%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 5 people, 31.25%
Hoarseness Or Changing Voice: 5 people, 31.25%
Weakness: 5 people, 31.25%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 6 people, 37.50%
Sinus Disorder (disease of sinus): 6 people, 37.50%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 25.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 12.50%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 6.25%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 6.25%
Mycobacterium Avium Complex Infection: 1 person, 6.25%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 6.25%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Synthroid and have Sputum retention?

- Check whether Sputum retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Synthroid:

Synthroid (249,205 reports)

Browse all side effects of Synthroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sputum retention:

Sputum retention (149 drugs)

Browse all the conditions that are associated with Sputum retention:

Sputum retention (317 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Synthroid) and Synthroid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.